The Belgian rider Jan Kuyckx (Davitamon-Lotto) tested positive for ephedrine and norpseudoephedrine during the Ster Elektrotoer, held between June 15-18 this year. Both his A and B samples revealed excessive concentrations of both restricted substances.
26 year-old Kuyckx was informed of the findings by his team early last month and hasn't been included on any race rosters since then. Davitamon-Lotto issued a statement on Saturday, saying that the rider probably didn't have bad intentions, as he was taking pseudoephedrine to counter the effects of an allergy that was prescribed to him by a doctor. Norpseudoephedrine (also known as cathine) is closely related to pseudoephedrine, a stimulant that was formerly restricted but is now permitted by the UCI and WADA, which can be converted to norpseudoephedrine in the body.
Davitamon-Lotto has stated they will not take any further measures against the rider, with Kuyckx himself saying he will appeal the findings. Earlier this year in May, Shimano memory Corp rider Stefan Schumacher also tested positive for norpseudoephedrine at the Rheinland-Pfalz-Rundfahrt, where won three of the five stages as well as the general classification, and was leading the UCI Europe Tour points classification at the time.